Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01553136 · ClinicalTrials.gov registry record · Phase 2
Varenicline Treatment of Alcohol Dependence in Smokers
A Phase 2 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 2
- Development phase
- 131
- Enrollment target
NCT01553136 is a Phase 2 study that has completed, run by Yale University. The registered enrollment target is 131 participants.
The verdict
NCT01553136, a Phase 2 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 131 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether varenicline is effective in the treatment of alcohol dependence in smokers.
Interventions
- DRUG Varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2012-09 |
| Est. Completion | 2016-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01553136
The ClinicalTrials.gov registry entry for NCT01553136 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 131 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Varenicline is the first listed.
NCT01553136 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01553136 about?
NCT01553136 is a clinical study titled "Varenicline Treatment of Alcohol Dependence in Smokers". The purpose of this study is to determine whether varenicline is effective in the treatment of alcohol dependence in smokers.
What is the current status of trial NCT01553136?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 131 participants. The study started on 2012-09. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01553136?
The interventions under investigation include: Varenicline (DRUG).
Who is sponsoring clinical trial NCT01553136?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.